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Abstract
Penicillin-binding protein A (PBPA) is a class B penicillin-binding protein that is important for
cell division in M. tuberculosis. We have determined a second crystal structure of PBPA in apo
form and compared it with an earlier structure of the apo enzyme. Significant structural
differences in the active site region are apparent, including increased ordering of a β-hairpin loop
and a shift of the SxN active site motif such that it now occupies a position that appears
catalytically competent. Using two assays, including one that uses the intrinsic fluorescence of a
tryptophan residue, we have also measured second-order acylation rate constants for the
antibiotics, imipenem, penicillin G and ceftriaxone. Of these, imipenem, which has demonstrable
antitubercular activity, shows the highest acylation efficiency. Crystal structures of PBPA in
complex with the same antibiotics were also determined and all show conformational differences
in the β5-α11 loop near the active site, but these differ for each β-lactam and also for each of the
two molecules in the crystallographic asymmetric unit. Overall, these data reveal the β5-α11 loop
of PBPA as a flexible region that appears important for acylation and provide further evidence that
PBPs in apo form can occupy different conformational states.
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INTRODUCTION
Penicillin-binding proteins (PBPs) are enzymes responsible for the final stages of cell-wall
formation in bacteria and are the molecular targets for β-lactam antibiotics 1. Essential PBPs
function as transpeptidases and catalyze the formation of cross-links between adjacent
peptides in peptidoglycan, while most non-essential PBPs are carboxypeptidases or
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endopeptidases. The hallmarks of these enzymes are three conserved motifs in the active
site: the SxxK motif, which contains the serine nucleophile, the SxN motif, and the KTG
motif 2. β-lactam antibiotics inhibit these enzymes by forming long-lived covalent
complexes that occupy the active site and prevent binding of the peptide substrate.
Although β-lactam antibiotics have been used successfully for treatment of both Gram-
negative and Gram-positive bacterial infections, they are considered to be clinically
ineffective against Mycobacterium tuberculosis (Mtb). One reason for their low efficacy is
that Mtb expresses the BlaC β-lactamase, which hydrolyzes these antibiotics before they
reach the PBP target 3. Several lines of evidence, however, suggest it is premature to
discount the value of β-lactams for treatment of tuberculosis. Deletion of the gene encoding
BlaC increases sensitivity of Mtb to β-lactams 4 and, in combination with inhibitors of β-
lactamase, β-lactams show bactericidal activity against numerous strains of M. tuberculosis
(Mtb), including multidrug-resistant (MDR) strains 5. Moreover, a combination of
amoxicillin and clavulanate shows some efficacy in patients with tuberculosis 6, and
meropenem in combination with clavulanate is potent against both aerobically and
anaerobically grown strains of Mtb, as well as laboratory strains of MDR and XDR Mtb 7,
and improves survival of mice infected with Mtb H37Rv 8. Finally, imipenem alone exhibits
antimycobacterial activity in both a mouse model of Mtb infection and in humans 9. Despite
the evidence that PBPs have strong potential as targets for anti-tubercular agents, there is
currently an absence of structural data for the interaction of Mtb PBPs with β-lactams.
Recently, we solved the crystal structure of PBPA from Mtb strain H37Rv in apo form 10.
PBPA is a Class B-type PBP 11 and, although it is not essential for cell growth 12, deletion
of the pbpA gene in M. smegmatis leads to reduced cell growth, defective cell morphology,
and impairment of cell division 13. PBPA is also of interest as it appears to be
phosphorylated by PknB 13, a serine/threonine protein-kinase whose gene is encoded in the
same operon as pbpa. Overall, the fold of PBPA is typical for PBPs, but it has a relatively
compact N-terminal domain (NTD) and an unusual conformation of the SxN active site
motif and the β5-α11 loop, which appears to restrict access to the active site, suggests that
conformational changes are necessary for the protein to undergo acylation 10. Another
interesting feature of the crystal structure is a disulphide bridge between the SxN motif
(SCN in PBPA) and a partially ordered region adjacent to the active site (referred to as the
β-hairpin region).
Here, we present a second crystal structure of PBPA in apo form that, when compared with
the first crystal structure, exhibits a more conventional conformation for the SxN motif and
the β-hairpin region is now ordered. We also determined crystal structures of acylated
complexes of PBPA with penicillin G, ceftriaxone and imipenem and compared these with
the second apo form. Major conformational changes in the β5-α11 loop are apparent in these
structures, which differ according to the specific β-lactam and also vary between molecules
in the asymmetric unit of the crystal structures. Second-order rate constants for the acylation
of PBPA by the same antibiotics were obtained using intrinsic fluorescence measurements
and SDS-PAGE-binding assays, and these are correlated with the crystal structures. Overall,
these data reinforce the notion that PBPs in apo form can adopt multiple conformations 14
and also reveal the β5-α11 loop as a flexible region of the active site that can adopt a variety
of conformations in the acylated state of PBPA.
RESULTS
Crystal structure of a second form of PBPA
The protein used to solve the previous structure of PBPA contained the His6 tag used for
purification 10. The striking features of that structure were disorder in a β-hairpin region that
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lies between the SxxK and SxN motifs, apparent blockage of the active site by the β5-α11
loop and an unusual architecture of the SxN motif that did not appear catalytically
competent. Whether by crystal soaking experiments or co-crystallization, structures of the
His-tagged protein as acylated complexes with β-lactams could not be obtained. For the
present study, the His6 tag was removed from PBPA by cleavage with TEV protease and the
resulting protein was purified and crystallized. Crystals were obtained with a very similar
crystallization condition as the previous apo structure and exhibited a similar hexagonal
morphology. Diffraction analysis revealed that the crystals belong to the same space group
(P61) with the same a (= b) cell dimension, but the c cell dimension had increased from 92
to 98 Å. As before, there are two molecules in the asymmetric unit, A and B.
Data extending to 2.0 Å were collected from these crystals and the structure was solved by
molecular replacement using the previous apo structure of PBPA as a search model (Table
I), which had been solved to 2.05 Å resolution 10. When compared to the previous structure,
the new structure of the untagged protein exhibits some interesting differences (Fig. S1).
One is the ordering of a region in the N-terminal domain of molecule A that exhibited
disorder in the His-tagged structure, but now forms a helix (α4n, residues 116–125) and an
extension to β6n, together with connecting loop (see 10 for secondary structure assignments).
The same region in molecule B also exhibits increased order, but part of α4n and the
connecting loop to β6n remain disordered. Also in molecule B, residues 371–385, which
form a β-hairpin (β2h-β2i) emanating from the TPase domain, are now ordered compared to
the first apo structure.
The most significant differences between the two apo structures of PBPA occur in the active
site region, most particularly in the SxN motif and in a loop above it that we term the β-
hairpin region (Fig. 1). The shift in the SxN active site motif is such that it now exhibits a
more conventional conformation when compared to other PBPs and one that is more likely
to represent the functional state of the enzyme. In the structure of the tagged protein, Ser281
of the SxN motif projected away from the active site and appeared to occupy a conformation
that was not catalytically competent. In the new structure, the SxN motif now occupies a
position closer to the active site and the side chain of Ser281 projects between Lys225 of the
SxxK motif and Lys424 of the KTG motif (Fig. 2). The shift of this residue is substantial:
the γ oxygen of the side chain has moved 5.4 Å in molecule A and 3.9 Å in molecule B. In
addition, it is interesting to note that the side chain of Ser222, the active site nucleophile, has
rotated to form a hydrogen bond with Lys225 in molecule B of the structure, but not in
molecule A, indicating variability in the position of this residue in the same PBP.
The most likely explanation for the dramatic shift in the SxN motif is a crystallographic one
and relates to increased ordering of the β-hairpin region that lies above it (as viewed in Fig.
1). Whereas a number of residues could not be modeled for the β-hairpin region in either
molecule of the asymmetric unit in the structure of the tagged protein due to weak or absent
electron density, all residues in this region are now completely ordered in both molecules of
the new structure and the main chain B factors in this region are all below 50 Å2. A
disulphide bridge between Cys282 (the “x” of the SxN motif) and Cys266 (in the β2c-β2d
loop) that connects the two regions provides a direct mechanism for the β-hairpin region to
influence the structure of the SxN motif. Other contacts that link the two regions are a
hydrogen bond between the side chain of Asn283 and the carbonyl of Glu259, and another
between Lys280 and the carbonyl of Cys266. In turn, increased order of the β-hairpin region
may have resulted from new crystal contacts that were absent in the previous structure due
to disorder. In molecule A, this region packs against the α9-β3 loop of molecule B and may
be responsible for disordering that is observed in the latter. The crystal contact for the same
region in molecule B is slightly different because it packs against the β4-β5 loop in addition
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to the α9-β3 loop of a neighboring molecule A. In contrast to molecule B, there is no
disordering the α9-β3 loop of molecule A.
Second-order rates constants of acylation for β-lactams
PBPA contains three tryptophans, one of which (Trp442) is close to the active site. To test
whether intrinsic tryptophan fluorescence could serve as a probe to monitor the covalent
binding of β-lactams, PBPA was excited at 295 nm and a peak at 332 nm was observed in
the intrinsic fluorescence emission spectrum (Fig. 3). Upon the addition of increasing
concentrations of penicillin G, the amplitude of the emission peak both decreased and
shifted to longer wavelengths (maximum shift was to 350 nm), suggesting that a
conformational change in the protein occurs upon acylation with β-lactams. A similar
concentration-dependent change in peak wavelength and amplitude was also observed upon
similar incubation with ceftriaxone, imipenem, or Bocillin-FL, a derivative of penicillin V
that contains a BODIPY fluorophore 15. Time-dependent changes in intrinsic fluorescence
were then used to calculate pseudo-first-order rate constants of acylation for each antibiotic
and are shown plotted against antibiotic concentration (Fig. 4). These varied linearly and the
slopes of the lines correspond to the second-order rate constants of acylation (k2/KS) at sub-
saturating concentrations of antibiotic (Table II).
The second order rate constant for acylation of PBPA by Bocillin-FL was also determined
by an SDS-PAGE binding assay and found to be essentially identical to the value
determined by intrinsic fluorescence. The k2/KS value for Bocillin-FL was then used to
derive k2/KS values for penicillin G, ceftriaxone and imipenem from IC50 values measured
in an SDS-PAGE competition assay (Table II; see Methods for details). The k2/KS values
derived from both methods were in excellent agreement for all of the β-lactams. Bocillin-FL
exhibited the highest rate of acylation, followed by imipenem, penicillin G and ceftriaxone.
Crystal structures of acylated complexes
In order to determine the effects of acylation on the structure of PBPA, crystal structures of
acylated complexes of PBPA with imipenem, penicillin G or ceftriaxone were determined
(Table I), and each is described below.
Imipenem structure—The structure of the acylated complex of PBPA with imipenem
was solved at 2.2 Å resolution. In both molecules of the asymmetric unit, the |Fo|−|Fc|
electron density corresponding to imipenem is well resolved except for the R2 side chain
(Fig. 5A). This is reflected in a difference of mean B factor between R2 group and the rest
of the antibiotic of 4.5 Å2 for molecule A and 7.2 Å2 for molecule B. In both molecules of
the asymmetric unit, the R2 group of imipenem is positioned between β3 and the β5-α11
loop, and its apparent flexibility may be due to the absence of hydrogen bonding that would
tether it to the enzyme. A similar weakness in density for the R2 substituent of imipenem
was also observed in a complex with P. aeruginosa PBP 3 16. Interestingly, the β5-α11 loop
is disordered in molecule A of the crystal structure, which might correlate with the weaker
density observed for the R2 group of imipenem in this molecule, whereas in molecule B,
density around the R2 group is more evident and the β5-α11 loop is ordered (see below).
Hydrogen-bonding interactions involving imipenem are broadly similar in both molecules of
the PBPA structure, but there are differences (Fig. 6A). In molecule A, the acyl linkage
carbonyl oxygen is close to the amide nitrogens of Ser222 and Thr427 (the oxyanion hole),
but is only within hydrogen bonding distance of Ser222 (2.7 Å) and not Thr427 (3.8 Å). In
molecule B, the carbonyl of the acyl linkage forms hydrogen bonds with both amide
nitrogens (3.2 and 2.6 Å, respectively). The slightly different position of the ring carboxylate
in both molecules also impacts hydrogen bonds. In molecule A, one oxygen of the ring
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carboxylate (O32) is 2.5 Å from the γ oxygen of Thr425 of the KTG motif and the other
(O31) contacts a water molecule. In molecule B, though, O31 hydrogen bonds with the γ
oxygen of Thr425 (2.5 Å) and O32 is within hydrogen bonding distance of the amide
nitrogen of Gly426 (2.8 Å). Finally, the slightly different position of the 6α-hydroxyethyl
group in each molecule means that the hydroxyl forms a hydrogen bond with the
carboxamide nitrogen of Asn283 in molecule B (2.8 Å to the oxygen and 2.7 Å to the
nitrogen), whereas it is beyond hydrogen-bonding distance in molecule A. By contrast, a
potential hydrogen bond between the ring nitrogen of imipenem and the hydroxyl of Ser281
(of the SxN motif) is essentially the same in both molecules (3.0 and 3.2 Å for molecule A
and B, respectively).
Penicillin G—The acylated complex of PBPA with penicillin G was determined at 2.3 Å
resolution. The density corresponding to penicillin G is well resolved in both molecules of
PBPA, except that the phenyl ring of the R1 side chain exhibits relatively weaker density in
the | Fo|−|Fc| electron density map, especially in molecule B where its exact position is
uncertain (Fig. 5B). Compared to the imipenem complex, the hydrogen bonding involving
penicillin G is essentially the same in both molecules of the asymmetric unit. The hydrogen-
bonding distances between the carbonyl oxygens and the respective amide nitrogens of
Ser222 and Thr427 are all the same (2.9 Å)(Fig. 6B). In addition, the carbonyl of the R
group of penicillin G forms hydrogen bonds with Asn283 (2.6 and 2.5 Å in molecule A and
B, respectively), similar to the interaction of the 6α-hydroxyethyl moiety of imipenem (in
molecule B). Finally, the ring nitrogen is within hydrogen-bonding distance of the Ser281
hydroxyl in both molecules (3.1 and 3.2 Å, respectively). Curiously, there is a surprising
difference between the two molecules of the asymmetric unit involving an interaction made
by the β-lactam carboxylate. As for the imipenem complex, an interaction between one of
the oxygens of the ring carboxylate (O12) and hydroxyl of Thr425 is present, but the
distance is much smaller (2.4 Å in molecule A and 2.6 Å in molecule B). This close
interaction is also observed in the complex with ceftriaxone (see below). The interaction
made by the other oxygen (O13), however, differs between the two molecules. In molecule
B, it is directly hydrogen bonded with the amide nitrogen of Gly472 of the β5-α11 loop, but
in molecule A, there is density between the two atoms, consistent with an intervening water
molecule. The marked difference in conformation of the β5-α11 loop in the two molecules
(see below) may be related to this alteration in hydrogen bonding.
Ceftriaxone—The complex with ceftriaxone was solved at 2.4 Å resolution and most of
the ceftriaxone fits well into the Fo|−|Fc| electron density map in the both molecules of the
asymmetric unit, including the R1 group. In both molecules, however, the methylester group
is not visible (Fig. 5C). In a situation similar to the complex with imipenem, hydrogen-
bonding interactions involving the acyl linkage carbonyl differ between molecules in the
asymmetric unit. In molecule A, the carbonyl oxygen is 4.1 Å from the amide nitrogen of
Thr427, whereas the corresponding distance in molecule B is 2.8 Å. Likewise, the distance
between the carbonyl and amide nitrogen of Ser222 is shorter in molecule A compared to
molecule B (2.6 vs. 3.0 Å). The close interaction between one oxygen of the ring
carboxylate and the γ hydroxyl of Thr425 is present (2.4 Å in molecule A and 2.6 Å in
molecule B). The other oxygen is within hydrogen bonding distance (3.0 Å) of the amide
nitrogen of Gly472 in molecule B, but not in molecule A (4.5 Å). Unlike the complex with
penicillin G, an intervening water between these groups is not observed in the electron
density. Like in the penicillin G complex, the R1 carbonyl and Asn283 form a potential
hydrogen bond (2.6 and 2.8 Å, respectively for molecule A and B). Hydrogen bonds
between the ring nitrogen and the Ser281 hydroxyl, however, are unlikely (3.6 Å in both
molecules) and this difference is likely to the six-membered dihydrothiazine ring present in
cephalosporins compared to the five-membered thiazolidine ring in penicillin. Finally, in
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molecule B, the amino group of 2-amino-4-thiaazolyl ring of ceftriaxone is 3.3 Å from the
carbonyl of Ala469, which is the only interaction observed in the three acylated structures
specific to an R group. The altered architecture of the β5-α11 loop precludes a similar
interaction occurring in molecule A.
Conformational changes associated with acylation
To determine what conformational changes occur as a result of acylation by β-lactam
antibiotics, the three acylated structures were compared to that of apo PBPA solved from
untagged protein (because this crystal form is isomorphous with the crystals used to generate
the structures of acylated complexes). A superimposition of the backbones of the apo
structure and the three structures of the acylated complexes shows that all structural
differences map to the active site region of the enzyme (see supplemental data, Fig. S2), but
differ according to the specific β-lactam and molecule in the asymmetric unit. The biggest
differences occur in the β5-α11 loop. In molecule A, this loop has shifted similarly in the
complexes with penicillin G and ceftriaxone, and has become disordered in the imipenem
complex, compared to the apo structure (Fig. 7A). In molecule B, this loop is structured in
all acylated complexes, but each has a different conformation (Fig. 7B). Since this loop
appears to block the active site in both apo structures of PBPA, large changes in its structure
were anticipated.
By comparison, other conformational differences between acylated and apo forms of PBPA
are lesser in magnitude. One of these occurs in the β3-β4 loop, which has shifted slightly in
the complexes with penicillin G and ceftriaxone compared to the apo structure (maximum
Cα-Cα carbon shifts in the loop are 1.2 and 1.3 Å for ceftriaxone and penicillin G
complexes, respectively). Interestingly, the β3-β4 loop is disordered in both molecules of the
imipenem complex structure, but why imipenem should impact this loop when its large R2
side chain points in the opposite direction is not clear. There is also a slight outward shift of
the β2c-β2d loop in the three acylated structures with respect to the apo structure. The
biggest changes occur in Tyr261 and Gly262 (the closest residues to the active site), with
Cα-Cα carbon shifts up to 2 Å observed in the imipenem- and ceftriaxone-acylated
structures and ~1 Å in the penicillin complex. Within the core of the active site itself,
changes are minimal and the positions of the three conserved motifs are essentially the same
in all structures. For example, in molecule B of the asymmetric unit, the RMS deviations for
main chain atoms of the active site residues between acylated and apo structures range from
0.2–0.3 Å, compared to 0.6–0.7 Å for the whole molecule. For molecule A, the range of
RMSD values is 0.35–0.48 Å for the active site residues and 0.4–1.2 Å for the whole
molecule. The disulphide bridge that connects the β-hairpin region with the SxN motif is
also unchanged. It is also worth noting that Trp442, the presumed probe for intrinsic
fluorescence, and its immediate environs are conformationally unchanged in all structures.
DISCUSSION
Following our structure determination of PBPA in apo form, which showed the active site
apparently blocked by the β5-α11 loop and an unusual conformation of the SxN motif 10, the
present study sought to examine the kinetic and structural behavior of PBPA in response to
acylation by β-lactam antibiotics in expectation of major conformational shifts. We obtained
a second crystal structure of PBPA in apo form from a protein construct lacking the His6
purification tag, which showed several differences in the active site compared to the
previous structure, and this crystal form enabled us to solve acylated structures of PBPA.
These data are now discussed in light of possible dynamic behavior of the active site of
PBPA and of conformational changes that occur in response to acylation by β-lactams.
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To assess the reactivity of PBPA toward antibiotics, we measured the acylation rates for
several β-lactams using two assays. One took advantage of the intrinsic tryptophan
fluorescence signal in the protein, presumably Trp422 that is located near the active site, that
decreases emission upon acylation of the protein by β-lactam antibiotics, and the other was
an SDS-PAGE-based competition assay using the fluorescent penicillin, Bocillin-FL 17. The
values provided by the two methods are strikingly consistent and validate the use of intrinsic
fluorescence to measure activity of PBPs when made possible by a suitably positioned
tryptophan residue. Compared to some other PBPs, e.g. PBP 2 from N. gonorrhoeae or PBP
2x of S. pneumoniae, both of which exhibit acylation rates for penicillin G above 50,000
M−1sec−1 18,19, PBPA shows only moderate sensitivity to β-lactams, but it is comparable to
others, e.g. S. pneumoniae PBP1b, which also exhibits similarly low rates with penicillin 20.
Of the four β-lactams tested, the order of k2/KS acylation rates, highest to lowest, was
Bocillin-FL > imipenem > penicillin G > ceftriaxone. The relatively higher activity with
imipenem is interesting as penems have demonstrable efficacy against M. tuberculosis,
including a mouse model of TB infection and in clinical treatment 7,9,21. For other PBPs
where rates of acylation have been measured against a series of β-lactams, different patterns
are observed. For example, whilst imipenem reacts with S. pneumoniae PBP 2x at a faster
acylation rate than penicillin G, and some cephalosporins (e.g. cefotaxime) react at higher
rates than both imipenem and penicillin, other cephalosporins (e.g. cephalexin) exhibit
acylation rates lower than all three 22. For N. gonorrhoeae PBP 2, two cephalosporins
(ceftriaxone and cefixime) both exhibit markedly higher rates of acylation compared to
penicillin G 18, which is opposite to PBPA. Finally, for E. coli PBP 5, the corresponding
order of acylation rates is cefoxitin (a cephalosporin) > imipenem > cloxacillin (a
penicillin) 23. Two points emerge from such data: 1) the acylation rates vary for the same
antibiotic against different PBPs, and 2) rates for different antibiotics directed against the
same PBP also vary and appear specific for that target.
It is difficult to explain the relative order of acylation rates based on the structural data
especially since, in all complexes, there is a paucity of specific interactions between the R1
or R2 groups and the enzyme, and because differences are observed between the two
molecules of the asymmetric unit. In fact, whilst imipenem has the highest rate of acylation
of the three antibiotics against PBPA, its R2 group is the least ordered of the β-lactam side
chains. Conversely, ceftriaxone has the lowest rate of acylation and yet its R1 group shows
the most ordered binding. The greater activity of imipenem may be due to its R2 group
projecting toward the β5-α11 loop, whereas the R1 groups of penicillin G and ceftriaxone
are directed toward the β2c-β2d loop on the opposite side of the active site. Hence, it is
possible that acylation rates are lowered by steric repulsion involving these R1 groups,
which would not occur with imipenem because it lacks an R1 group.
The apparent disorder in the R1 or R2 groups of the β-lactams in the crystal structures is
unexpected and contrasts with some complexes of other PBPs where electron densities for
these regions are well defined 24–28. Our findings are similar, however, to those we reported
for E. coli PBP 5, where, in crystal structures of acylated complexes, electron density for the
R1/R2 substituents of various β-lactams was also consistently weak and did not correlate
with acylation rates 29. Such data reinforce the notion that acylated complexes of PBPs with
β-lactams may only be of limited value when rationally designing new inhibitors of PBPs
because these may not reveal interactions that occurred during acylation 23. In support of
this, crystal structures of the AmpC β-lactamase in the pre-covalent, acylated and post-
covalent product state show significantly different modes of binding for cephalothin 30.
One surprise in the acylation data is the nearly 3-fold difference in rate between penicillin G
and Bocillin-FL. The latter differs from penicillin G by having an ester linkage to the R1
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phenol group (because it is a derivative of penicillin V) and by containing a BODIPY
fluorophore attached to the para-position of the phenol group via an intervening amide
group. Either or both of these differences could be responsible for the different rates. Data
collected from crystals of PBPA that had been soaked in Bocillin-FL (at different molarities
and with various soak times) consistently showed evidence of acylation of Ser222 in the
active site, but density beyond that was uninterpretable and none of the R1 group was visible
(data not shown). One possible explanation for weak density of Bocillin-FL is that, whilst
the β-lactam ring can access the serine nucleophile, the large R1 group with its pendant
BODIPY group does not bind the protein and is disordered.
The previous structure of PBPA in apo form showed disorder in the β-hairpin region, a
conformation for the SxN motif that did not appear catalytically competent, and an active
site that appeared to be occluded by the β5-α11 loop 10. At the time, we assumed that major
conformational changes would be required during reaction with β-lactams (and
peptidoglycan substrate). The second structure of PBPA in apo form reported here was
determined using protein devoid of its purification tag, which generated a slightly altered
crystal form. This structure shows increased order in the β-hairpin region and a canonical
position for the SxN motif, but the β5-α11 loop remains in a similar position. The
conformational differences observed between two apo forms of PBPA is reminiscent of S.
pneumoniae PBP 1b in which there are “open” and “closed” architectures involving
movement of three loops near the active site in two forms of the apoenzyme 14. In the case
of PBPA, a new crystal contact between Gly253, which lies on the β-hairpin region between
β2b and β2c, and the α9-β3 loop of neighboring molecule may be responsible for greater
ordering of the β-hairpin region and this, in turn, may alter the conformation of the SxN
motif through the disulphide bridge between Cys266 and Cys282. It appears therefore that
structural changes observed between apo forms are a consequence of slightly different
crystal packing of the His-tagged vs. untagged forms of PBPs, and in support of this,
acylation rates for the tagged versus untagged protein are essentially identical. How the tag
itself influences crystallization is unclear because in both apo structures, the traceable model
begins at around residue 45 and residues prior to that, including the tag in the first apo
structure, are not visible.
It is notable that the β-hairpin region of PBPA was disordered in the first structure of apo
PBPA but is now ordered in the new structure, because it suggests this area of the molecule
is not rigid and can adopt different conformations depending on the crystallographic packing
interactions of different crystal forms. This is interesting because it is broadly equivalent to a
region of S. pneumoniae PBP 2x comprising residues 364–395 leading up to the SxN motif
that exhibits order in the enzyme derived from the penicillin-susceptible strain R6 31, but is
disordered in PBP 2x from the penicillin-resistant strain Sp328 32. This difference was
suggested as the cause for lowered acylation efficiency of Sp328-PBP2x, but, because the
two crystal structures were obtained from different crystal forms (P41212 vs. P32), the
observed structural changes could be a consequence of crystallization and unrelated to
penicillin resistance. That said, this region is apparently more susceptible to proteolytic
digestion in PBP2x derived from resistant strains, but not susceptible strains 33, which is
corroborating evidence of increased flexibility in this loop. Nevertheless, since the only
difference between the two PBPA proteins is the presence of a purification tag, with no
discernable effect on acylation efficiency by β-lactams, our findings urge a cautionary
approach to the interpretation of purely crystallographic data.
We also observed evidence of flexibility in our three structures of PBPA in acylated form.
The key element involved in these structures is the β5-α11 loop, which has shifted or
become disordered in all three acylated complexes, in agreement with the expectation that
this loop would move during acylation to allow access to the active site. Interestingly, the
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loop exhibits a variety of conformations (or degrees of order) depending on the specific β-
lactam, and also changes between the two molecules in the asymmetric unit. For the
imipenem complex, the β5-α11 loop is disordered in molecule A and has shifted in molecule
B (compared to the apo structure). Its position may be dictated by the R2 substituent of
imipenem, which, in both molecules of the asymmetric unit, points toward the loop. For the
complex with penicillin G, even though the β5-α11 loop is ordered in both molecules of the
asymmetric unit, there are surprising differences in its conformation depending on whether
an interaction between ring carboxylate and loop is direct or involves a bridging water
molecule. The β5-α11 loop also adopts different conformations in each molecule of the
ceftriaxone complex, even though the binding mode of ceftriaxone is very similar in both.
The importance of the β5-α11 loop for acylation is also highlighted by shifts in this region
between apo and acylated forms of PBP3 from P. aeruginosa 16 and in S. pneumoniae
PBP1b 14,20 and the fact that two Arg to Gln mutations in this loop in S. pneumoniae PBP1b
lower second-order acylation rate constants for β-lactams by several fold 20. Likewise, we
have shown that mutation of Gly545 to Ser in the β5-α11 loop in N. gonorrhoeae PBP 2
lowers the acylation rates with penicillin and expanded-spectrum cephalosporins 18. Hence,
the β5-α11 loop is emerging as an important functional region for acylation of PBPs,
alongside other well-established regions such as the β3-β4 loop 20,28,34,35.
In conclusion, a second structure of Mtb PBPA in apo form provides evidence that PBPs can
occupy different conformational states in solution and even within a single crystal. Kinetic
measurements of the acylation efficiency of the enzyme using several β-lactams shows that
PBPA reacts relatively poorly compared with other PBPs, but the highest activity with
imipenem may correlate with its clinical efficacy. Conformational changes induced by
acylation center on the β5-α11 loop of the active site and are specific for each β-lactam.
Overall, these data highlight the importance of the β5-α11 loop in the active-site dynamics
of PBPs and reactivity with β-lactams.
MATERIALS & METHODS
Materials
Penicillin G, ceftriaxone, and imipenem were purchased from Sigma (St. Louis, MO), and
Bocillin-FL from Invitrogen (Carlsbad, CA).
Protein purification
A soluble form of wild-type PBPA lacking its transmembrane anchor and signal sequence
(residues 1–33) was cloned into pT7HTb, expressed in E. coli BL21 DE3 cells, refolded and
purified by Ni2+-affinity chromatography, as described previously 10. This protein contains a
hexahistidine tag and intervening cleavage site for tobacco etch virus (TEV) protease. To
remove the tag, the fusion protein was dialyzed against buffer A (20 mM Tris-HCl, pH 8.0,
0.5 M NaCl, 10% glycerol, 20 mM imidazole) overnight at 4 °C and then mixed with His6-
tagged TEV-protease in a 50:1 ratio (w/w). PBPA was isolated from the digest by a second
passage over Ni+2-affinity column (HisTrap HP, GE Healthcare) that had been equilibrated
with buffer A. PBPA eluted in the flow-through and was concentrated to 9 mg/ml.
Kinetic analysis of the interaction of PBPA with β-lactams
PBPs react with β-lactam antibiotics according to the kinetic scheme:
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where E•S is the non-covalent Michaelis-Menten complex, E-S is the covalent acyl-enzyme
complex, and P is the product after deacylation. For β-lactams, the deacylation rate is very
slow and so the second-order acylation rate constant (k2/KS), which corresponds to the initial
rate of formation of covalent β-lactam adducts, is used as a measure of the potency of an
antibiotic. At sub-saturating conditions, when [S] < Km, the kinetics are described by
equation (1):
(1)
where [S] is the β-lactam concentration, ka is the pseudo-first-order rate constant of E-S
formation at a given [S] value, v is the initial rate of formation of E-S, and Et is total enzyme
concentration 36. The second-order acylation rate constants for the reaction of PBPA with
penicillin G, ceftriaxone, imipenem, and the fluorescent penicillin Bocillin-FL 15 were
determined measuring time-dependent decreases of PBPA intrinsic fluorescence and SDS-
PAGE binding assays.
Intrinsic fluorescence
Intrinsic fluorescence emission spectra of PBPA were recorded at 36°C on a Quanta Master
fluorimeter (QM4, Photon Technology International, Inc., Birmingham, NJ) with
fluorescence excitation at 295 nm and emission at 332 nm (slit widths of 2 nm and 4 nm,
respectively). For all experiments, PBPA was diluted into 2 ml of binding buffer (50 mM
sodium phosphate, pH 8) to a final concentration of 0.5 μM and then mixed with β-lactams.
The time-dependent decrease of intrinsic fluorescence was recorded immediately after
addition of each β-lactam in the sub-saturating concentration range of 2 to 25 μM. At least
three independent measurements were performed at each β-lactam concentration. Data were
corrected for the buffer and ligand background signals. Using equation (1), k2/KS was
derived from a plot of ka vs [S], where the slope of the line defines the second-order
acylation rate constant.
SDS-PAGE-based binding assays
PBPA (1 μM) was incubated at 36°C with 2.5, 5, 8, 10, or 12 μM Bocillin-FL. Every 10–30
sec, 20 μl aliquots were removed, mixed with 5 μl of SDS-PAGE sample buffer and boiled
at 98°C for 2 min. Acylated PBPA was then separated from free label using 10% Mini-
Protean TGX SDS-PAGE gels (Bio-Rad, Hercules, CA). At least two independent reactions
were performed in duplicate at each antibiotic concentration. Gels were scanned using a
Kodak EDAS 290 UV imaging system (Scientific Imaging Systems, Eastman Kodak,
Newhaven, CT, USA), following which the gels were stained with Coomassie R-250 to
confirm equivalent loading. Densitometry was performed with the ImageJ 1.37 program
(National Institutes of Health, USA; http//rsb.info.nih.gov/ij/) and data points were
normalized to the maximum of the fluorescence intensity (defining complete saturation of
PBPA by Bocillin-FL). ka values were determined at each antibiotic concentration from
plots of % bound versus time using nonlinear regression analysis and the k2/KS of Bocillin-
FL was derived from a plot of ka versus [S].
In the competition assay, PBPA (1 μM) was incubated with 10 μM Bocillin-FL in the
presence of increasing concentrations (0.05 – 1000 μM) of an unlabeled β-lactam (penicillin
G, ceftriaxone, or imipenem) in 20 μl final volume at 36°C for 15 min and PBPA bound by
Bocillin-FL was quantified by densitometry after SDS-PAGE. Data from four independent
experiments (in duplicate for each antibiotic) were used to determine IC50 values, from
which second-order acylation rate constants were derived using equation (2) 36:
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where (k2/KS)U is the rate constant of an unlabeled compound, (k2/KS)L is the rate constant
of Bocillin-FL, and [SL] is the concentration of Bocillin-FL used in the competition
experiment.
All curve fitting analysis and calculations for both intrinsic fluorescence and SDS-PAGE
methods were performed using GraphPad Prism version 4.00 for Windows (GraphPad
Software, Inc, San Diego, CA).
Crystallization, data collection and structure refinement of the new apo form and acylated
complexes
Crystals of PBPA were grown using the hanging drop vapor diffusion method at room
temperature over wells containing 25–27% PEG 3350, 0.2 M NaCl and 0.1 M Bis-Tris pH
5.5–5.6. To generate acylated complexes, crystals were soaked in 100 mM penicillin G for 3
hours or 100 mM ceftriaxone for 2 hours. Crystals used to solve the complex with imipenem
were grown over 20% PEG 3350 and 0.2 M potassium nitrate, and were soaked in 16 mM of
the antibiotic for 5 hours. All crystals were cryoprotected by passage through the respective
mother liquor to which ethylene glycol had been added to a final concentration of 30% and
then frozen in liquid nitrogen.
X-ray diffraction data were collected at the SER-CAT ID-22 beam line of the Advanced
Photon Source (Argonne National Laboratory, Chicago, IL) at 1.00 Å wavelength. The
crystals belong to space group P61, with cell dimensions of ~a=b=122 Å and c=98 Å and
two molecules in the asymmetric unit. All data were processed with HKL2000 37. The
starting model for refinement was the previous structure of PBPA in apo form, but stripped
of all water molecules 10. For each acylated structure, after an initial round of rigid-body and
restrained refinement using REFMAC5 38, (|Fo|−|Fc|) and 2(|Fo|−|Fc|) maps were calculated
and used to model the β-lactam and rebuild the protein using O 39. The PRODRG server was
used to generate stereochemical libraries for the refinement of each antibiotic 40. The model
was then improved by further rounds of manual building and REFMAC, including
introduction of ordered water molecules. All atoms were refined with an occupancy of 1,
including those of the antibiotics. The geometry of the four structures was validated by
PROCHECK 41. In all structures, residues Ser96, Ala99 and Lys340 consistently lie outside
favored regions of the Ramachandran plot, but occupy excellent electron density. Some
features in the electron density maps indicating binding of unknown ligands from the
crystallization or soaking solutions could not be modeled.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Apoenzyme forms of PBPA from M. tuberculosis exhibit altered active site
structures.
• Of several β-lactams tested, imipenem acylates PBPA at the highest rate.
• Acylation of PBPA by β-lactams induces large shifts in the β5-α11 active site
loop.
• PBPA exhibits dynamic behavior prior to and during acylation by β-lactams.
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A comparison of two structures of Mtb PBPA in apo form. The new apo structure was
superimposed with an apo structure determined previously 10 and structural differences in
the active site region are shown for both molecules in the asymmetric unit. In this
stereoview, the Cα backbone of the previous (His-tagged) apo structure is colored grey and
that of the new apo structure (untagged) is blue. Elements of secondary structure are labeled
and the disulfide bridge linking the β-hairpin region with the SxN motif is shown in green.
Note the increased ordering of the β-hairpin region in the new apo structure.
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Superimposition of the two apo forms in the active site region showing the canonical
position for the SxN motif in the new structure of PBPA. In this stereoview, the previous
apo structure (His-tagged) is displayed as a grey backbone with yellow bonds, and the new
apo structure is a blue backbone with orange bonds. In the latter, Ser281 of the SxN motif
now lies in a canonical position and mediates hydrogen bonds with Lys424 (dashed lines).
Only molecule A of the asymmetric unit is shown, but the shift is very similar in molecule
B.
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Intrinsic fluorescence emission scans of PBPA (0.5 μM) following excitation at 292 ± 2 nm
and titrated with increasing concentrations of penicillin G from 0 to 1 mM. Fluorescence
emission shows increasing quenching and shift of the maximum as acylation of the PBP
increases.
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Determination of second-order acylation rate constants for the interaction between PBPA
and β-lactam antibiotics using data measuring intrinsic fluorescence. Second order rate
constants (k2/KS) were derived from plot of ka vs [S], where k2/KS corresponds to the slope
of the line.
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Electron density of antibiotics in the acylated structures of PBPA. In each case, |Fo|−|Fc|
difference electron density is shown, calculated after a refinement in which the occupancy of
the atoms corresponding to each β-lactam and Ser222 were set to zero. A. imipenem
contoured at 2.5 σ. B. penicillin G, contoured at 2.8 σ. C. ceftriaxone, contoured at 2.5 s.
Density for both molecules of the asymmetric unit are shown, with molecule A on the left
and molecule B on the right. In all cases, Ser222 is colored with yellow bonds and the
antibiotic is colored with green bonds.
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Contacts made by each antibiotic and position of the β5-α11 loop in acylated structures of
PBPA. Each panel shows a stereo view of the active site after superimposition of molecule
A with molecule B of the asymmetric unit, where the latter is rendered with transparency.
The Cα backbone is colored as follows: β3 containing the KTG motif is blue, α2 containing
the SxxK motif is pink, the α4-α5 loop containing the SxN motif is orange, and the β5-α11
loop is grey. Selected residues are displayed with yellow bonds and each antibiotic is
displayed with green bonds. Potential hydrogen bonds are shown as dashed lines. A,
imipenem; B, penicillin G, and C, ceftriaxone.
Fedarovich et al. Page 21














Superimposition of the active sites of PBPA and of the three acylated structures. Each
structure is displayed as a Cα backbone where apo PBPA is grey, the complex with
imipenem is blue; that for penicillin G is green and that for ceftriaxone is orange. Imipenem,
penicillin G and ceftriaxone are also shown in bonds form with corresponding colors.
Elements of secondary structure are labeled according to 10 and the disulfide bridge between
the β-hairpin region and the SxN motif is also shown. Superimpositions of both molecules of
the asymmetric unit are shown: A, molecule A and B, molecule B.
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Table I
Data collection and refinement statistics
Antibiotic Apo Imipenem Penicillin G Ceftriaxone
Molarities of soak (mM) - 16 100 100
Time of soak (hrs) - 5 3 2
Wavelength (Å) 1.00 1.0 1.0 1.0
Resolution range (Å) 46.1 – 2.0 (2.03 –
2.00)
39.0 – 2.2 (2.28 –
2.20)
44.3 – 2.3 (2.38 –
2.30)
45.7 – 2.4 (2.49 –
2.40)
Rmerge1 (%) 11.8 (70.6) 8.4 (55.2) 8.0 (49.7) 8.0 (62.3)
Redundancy 12.4 (6.2) 14.9 (8.8) 10.9 (8.6) 10.2 (7.3)
Completeness (%) 99.9 (99.3) 99.3 (96.1) 98.1 (91.1) 98.7 (89.6)
<I>/<σI> 35.4 (2.1) 40.3 (2.5) 34.0 (2.7) 34.5 (2.2)
Number of water molecules 193 58 48 21
Crystallographic R factor (%) 20.5 21.6 19.7 20.3
R work (%) 20.4 21.4 19.5 20.1
R free (%) 23.5 25.7 24.3 24.7
RMS deviations from ideal stereochemistry:-
 bond lengths (Å) 0.010 0.011 0.011 0.010
 bond angles (°) 1.30 1.33 1.35 1.36
Mean B factors (Å2):
 all atoms 37.5 44.6 46.6 53.0
 main chain 36.5 43.8 45.8 52.3
 side chain & waters 38.6 45.5 47.6 53.8
 antibiotic - 66.9 53.5 64.3
Ramachandran plot:
 % residues in most favored region 91.6 92.0 90.1 90.3
 % residues in additionally allowed regions 7.5 7.0 9.1 8.8
 % residues in generously allowed regions 0.6 0.7 0.4 0.7
 % residues in disallowed regions 0.3 0.3 0.4 0.1
RMSD1 of Cα atom with native structure (Å)
(molecule A/molecule B)
- 0.42/0.62 1.18/0.76 1.25/0.79
PDB code 3UN7 3UPN 3UPO 3UPP
1
Superimposition performed using all common main chain atoms in the residue range 50–488. All atoms were refined with an occupancy of 1.
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Table II
Kinetic parameters for the interaction between PBPA and β-lactam antibiotics




Bocillin-FL 7,610 ± 250 7,100 ± 430
Penicillin G 2,650 ± 100 2,860 ± 130
Ceftriaxone 1,660 ± 100 1,680 ± 100
Imipenem 3,980 ± 180 4,110 ± 380
Data values represent mean ± SEM (standard error of the mean)
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